PDF herunterladen
Erfahrungsheilkunde 2012; 61(2): 79-83
DOI: 10.1055/s-0031-1298676
Übersichten/Reviews
© Karl F. Haug Verlag MVS Medizinverlage Stuttgart GmbH & Co. KG

Rhodiola rosea-Spezialextrakt SHR-5 bei Burn-out und Erschöpfungssyndrom

Ergebnisse einer Praxisstudie zur Wirksamkeit
Birgit Goyvaerts
,
Stefan Bruhn
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
27. April 2012 (online)

    Lizenzen und Reprints

Zusammenfassung

In der vorliegenden Praxisstudie wurden Wirksamkeit und Verträglichkeit des Rhodiola rosea-Wurzelextrakts SHR-5 (Prüfpräparat: Rhodiolan® NE) bei Patienten mit Burn-out- und Erschöpfungssyndrom untersucht. Bei den erfassten Symptomen (Erschöpfung, depressive Verstimmung, Schlafstörungen, Müdigkeit, Leistungsabfall) zeigte sich über den Beobachtungszeitraum von 8 Wochen ein hochsignifikanter und kontinuierlicher Rückgang der Beschwerdeintensität um bis zu 63 % bei sehr guter Verträglichkeit.

Abstract

In the present study we investigated efficacy and tolerability of Rhodiola rosea root extract SHR-5 (Rhodiolan® NE) in patients with burnout and fatigue syndrome. Five symptoms (fatigue, exhaustion, depression, insomnia, loss of power) were recorded over 8 weeks and taken together in a sum score. The Rhodiola extract showed an impressive highly significant and continuos decline of the complaints up to 63 % together with very good tolerability.

Schlüsselwörter

Rosenwurz - Rhodiola rosea - SHR-5 - Burn-out - Erschöpfung

Keywords

Arctic root - Rhodiola rosea - SHR-5 - burnout - fatigue
 

  • Literatur

  • 1 Brown R, Gerbarg PL, Ramazanov Z. Rhodiola rosea – a phytomedicinal overview. Herbal Gram 2002; 56: 40-52
    PubMedSuche in Google Scholar
  • 2 Darbinyan V, Kteyan A, Panossian A et al. Rhodiola rosea in stress induced fatigue – a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine 2000; 7 (5): 365-371
    CrossrefPubMedSuche in Google Scholar
  • 3 Darbinyan V, Aslanyan G, Amroyan E et al. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nord J Psychiatry 2007; 61: 343-348
    CrossrefPubMedSuche in Google Scholar
  • 4 Grünwald J, Stier H, Bruhn S, Goyvaerts B. Rhodiola rosea: Ein Adaptogen bei Burnout. ZPT 2011; 32 (4): 161-163
    PubMedSuche in Google Scholar
  • 5 Olsson E, von Scheele B, Panossian A. A randomized, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med 2009; 75 (2): 105-112
    Thieme ConnectPubMedSuche in Google Scholar
  • 6 Panossian A, Wikman G. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Current Clinical Pharmacology 2009; 4: 198-219
    CrossrefPubMedSuche in Google Scholar
  • 7 Shevtsov V, Zholus B, Shervarly V et al. A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine 2003; 10: 95-105
    CrossrefPubMedSuche in Google Scholar
  • 8 Spasov A, Wikman G, Mandrikov V et al. A double blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-doses regimen. Phytomedicine 2000; 7 (2): 85-89
    CrossrefPubMedSuche in Google Scholar